Abstract | OBJECTIVE: To test whether the serial measurement of maternal levels of compound W, a 3,3'-diiodothyronine sulfate cross-reactive substance, can serve as a potential indicator of fetal thyroid function in pregnant women receiving antithyroid medication. METHODS: RESULTS: CONCLUSION: Normal progression of maternal serum compound W may be an index of normal fetal thyroid development in mothers with hyperthyroidism treated with necessary antithyroid medication.
|
Authors | Lester Vanmiddlesworth, N Rue Vanmiddlesworth, Robert S Egerman, Andrew J Bush, Risa D Ramsey, Lucinda P Delmar, Eugene C Ho, Sing-Yung Wu |
Journal | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
(Endocr Pract)
2011 Mar-Apr
Vol. 17
Issue 2
Pg. 170-6
ISSN: 1934-2403 [Electronic] United States |
PMID | 20713348
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antithyroid Agents
- Diiodothyronines
- compound W
- Thyroxine
|
Topics |
- Adolescent
- Adult
- Antithyroid Agents
(adverse effects, therapeutic use)
- Diiodothyronines
(blood)
- Female
- Humans
- Hyperthyroidism
(blood, drug therapy)
- Infant, Newborn
- Pregnancy
- Thyroid Gland
(embryology)
- Thyroxine
(blood)
- Young Adult
|